bicalutamide and Heart Failure

bicalutamide has been researched along with Heart Failure in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cassidy-Bushrow, AE; Haque, R; Keating, NL; Potosky, AL; Tsai, HT; UlcickasYood, M; Van Den Eeden, SK; Xu, X	1
Guirguis, K	1
Bhattacharya, S; Chowdhury, S; Hasabou, N; Heidenreich, A; Klotz, L; Shore, ND; Siemens, DR; van Os, S; Villers, A; Wang, F	1

Trials

1 trial(s) available for bicalutamide and Heart Failure

Article	Year
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. The Lancet. Oncology, 2016, Volume: 17, Issue:2 Topics: Aged; Aged, 80 and over; Anemia; Anilides; Arthralgia; Back Pain; Benzamides; Constipation; Disease Progression; Disease-Free Survival; Double-Blind Method; Dyspnea; Fatigue; Fractures, Spontaneous; Heart Failure; Hot Flashes; Humans; Hydronephrosis; Hypertension; Male; Middle Aged; Myocardial Infarction; Nausea; Nitriles; Patient Dropouts; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Tosyl Compounds	2016

Article

Year

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.

The Lancet. Oncology, 2016, Volume: 17, Issue:2

Topics: Aged; Aged, 80 and over; Anemia; Anilides; Arthralgia; Back Pain; Benzamides; Constipation; Disease Progression; Disease-Free Survival; Double-Blind Method; Dyspnea; Fatigue; Fractures, Spontaneous; Heart Failure; Hot Flashes; Humans; Hydronephrosis; Hypertension; Male; Middle Aged; Myocardial Infarction; Nausea; Nitriles; Patient Dropouts; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Tosyl Compounds

2016

Other Studies

2 other study(ies) available for bicalutamide and Heart Failure

Article	Year
Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. British journal of cancer, 2017, Oct-10, Volume: 117, Issue:8 Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Arrhythmias, Cardiac; California; Cardiovascular Diseases; Cohort Studies; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Heart Failure; Humans; Imidazolidines; Leuprolide; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Nitriles; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Tosyl Compounds	2017
Bicalutamide causes heart failure in an elderly patient with prostate cancer. Expert opinion on drug safety, 2016, Volume: 15, Issue:3 Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Apoptosis; Heart Failure; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds	2016

Article

Year

Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.

British journal of cancer, 2017, Oct-10, Volume: 117, Issue:8

Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Arrhythmias, Cardiac; California; Cardiovascular Diseases; Cohort Studies; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Heart Failure; Humans; Imidazolidines; Leuprolide; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Nitriles; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Tosyl Compounds

2017

Bicalutamide causes heart failure in an elderly patient with prostate cancer.

Expert opinion on drug safety, 2016, Volume: 15, Issue:3

Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Apoptosis; Heart Failure; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds

2016